Juvederm brochure 8 points lift

13
the -point lift lift -p - -p A clinician’s guide to

description

juvederm 8 point lift www.dokterfrodo.nl

Transcript of Juvederm brochure 8 points lift

Page 1: Juvederm brochure 8 points lift

the -point lift-point lift-point -point -point -point

A cl in ic ian’s guide to

Page 2: Juvederm brochure 8 points lift

Facial enhancement and rejuvenation have moved beyond wrinkle effacement

and surgical facelifts - to an approach that volumizes and structures.

This comprehensive, multimodal approach permits clinicians to develop aesthetic

treatment plans tailored to individual patient needs and designed to produce a

natural look.1

The 8-point lift is a new approach, utilizing the new VYCROSSTM collection of hyaluronic

acid (HA) dermal fi llers for facial rejuvenation and shaping. The procedure, developed

by Dr Mauricio de Maio, is delivered in 8 distinct treatment areas to achieve the most

natural result and maintain each patient’s unique facial expressions.2,3

Treatment is individualized to each patient using the Juvéderm® family of HA fi llers –

including Juvéderm® VOLBELLA® with Lidocaine, Juvéderm® VOLIFT® with Lidocaine and

Juvéderm® VOLUMA® with Lidocaine.

The procedure recommends a sequence of injection and specifi c sites that should be

adapted based on each patient’s profi le to achieve the optimal outcome. This booklet aims

to provide clinicians with the information needed to carry out the 8-point lift with confi dence.

Facial enhancement and rejuvenation

and surgical facelifts - to an approach that

This comprehensive, multimodal approach permits clinicians to develop aesthetic

Facial enhancement and rejuvenation

and surgical facelifts - to an approach that

This comprehensive, multimodal approach permits clinicians to develop aesthetic

treatment plans tailored to individual patient needs and designed to produce a 1

Facial enhancement and rejuvenation

and surgical facelifts - to an approach that

This comprehensive, multimodal approach permits clinicians to develop aesthetic

treatment plans tailored to individual patient needs and designed to produce a

Facial enhancement and rejuvenation

and surgical facelifts - to an approach that

This comprehensive, multimodal approach permits clinicians to develop aesthetic

treatment plans tailored to individual patient needs and designed to produce a

the -point lift-point lift-point lift-point lift

Page 3: Juvederm brochure 8 points lift

Volume loss and the ageing process

Volume loss and the ageing process

-HJPHS�]VS\TL�SVZZ�JVU[YPI\[LZ�ZPNUP�JHU[S`�[V�MHJPHS�HNLPUN��=VS\TL�KL�JP[Z�HYL�H�YLZ\S[�VM�[OL�SVZZ�HUK�YLWVZP[PVUPUN�VM�MHJPHS�MH[��HZ�^LSS�HZ�MYVT�ZRLSL[HS�YLTVKLSPUN�1

)`�SVVRPUN�MVY�MHJPHS�ZOHKV^Z�HUK�KLWYLZZPVUZ�^OLU�HZZLZZPUN�H�WH[PLU[��P[�PZ�WVZZPISL�[V�OLSW�PKLU[PM`�^OLYL�[OPZ�]VS\TL�OHZ�ILLU�SVZ[��;`WPJHSS �̀�[OPZ�VJJ\YZ�PU�[OL�MVSSV^PUN�HYLHZ�VM�[OL�MHJL����

Key areas of volume loss:

Tear trough and infraorbital area

*VUJH]P[`�\UKLY�[OL�L`L�HYLH�PZ�K\L�[V�JOHUNLZ�PU�ZVM[�[PZZ\L�HUK�ZRLSL[HS�Z[Y\J[\YL��;OPZ�JYLH[LZ�OVSSV^�KLWYLZZPVUZ�HUK�Å�H[[LUPUN�VM�[OL�JOLLRZ��[OH[�JHU�JVU[YPI\[L�[V^HYKZ�H�º[PYLK�SVVR»�

Nasolabial fold and the effect of gravity

3VZZ�VM�LSHZ[PJP[`�JVTIPULK�^P[O�[OL�LMMLJ[�VM�NYH]P[`�JHU�SLHK�[V�H�TVYL�WYVTPULU[�UHZVSHIPHS�MVSK�

Malar region

=VS\TL�SVZZ�PU�[OL�THSHY�YLNPVU�JVU[YPI\[LZ�[V�SVVRPUN�VSK�HUK�\U^LSS�

Page 4: Juvederm brochure 8 points lift

Mouth frown

6]LY�[PTL��[OLYL�PZ�H�SVZZ�VM�[OL�\W^HYK�[\YUPUN�VM�[OL�TV\[O�JVYULYZ�

Pre-jowl area

;OL�WYL�QV^S�KLWYLZZPVU�PZ�[OL�YLZ\S[�VM�ZHNNPULZZ��ZRPU�SH_P[`�HUK�Z\IJ\[HULV\Z�MH[�SVZZ�HUK�YLKPZ[YPI\[PVU��[OH[�NYHK\HSS`�HWWLHY�^P[O�HNLPUN�HUK�JYLH[L�H�OLH]`�HWWLHYHUJL�[V�[OL�SV^LY�MHJL�

Jawline

;OLYL�PZ�H�SVZZ�VM�KL�UP[PVU�PU�[OL�QH^SPUL�K\L�[V�HNLPUN���

*OLLR�IVUL�KL�UP[PVU�HUK�Z[Y\J[\YL

@V\[OM\S�JOLLRZ�UH[\YHSS`�OH]L�TVYL�]VS\TL�^OPJO�THRLZ�[OLT�ZTVV[O�HUK�^LSS�KL�ULK��>P[O�HNLPUN��[OPZ�`V\[OM\S�KL�UP[PVU�PZ�NYHK\HSS`�SVZ[�HZ�]VS\TL�SL]LSZ�HYL�KLWSL[LK�

Recognition of volume loss in facial ageing is the basisfor facial rejuvenation, infl uencing the types and

extent of surgical procedures, as well as the way in which minimally invasive approaches are employed.1

Restoring volume with the VYCROSSTM collection of fi llers

Page 5: Juvederm brochure 8 points lift

Enhancement of lip and

perioral areas and reduction

RI�ð�QH�OLQHV

,QGLFDWHG�IRU�ð�OOLQJ�medium-deep depressions

Restores facial volume

LQFOXGLQJ�FKHHNV��FKHHNERQH��DQG�FKLQ

94200JR 94201JR94504JR

94506JR

1 x 1 mL 2 x 1 mL1 x 2 mL

2 x 1 mL

���PJ�P/ �����PJ�P/ ���PJ�P/

Yes 0.3%

Z�Z�/LGRFDLQH(HCI)

Yes 0.3%

Z�Z�/LGRFDLQH(HCI)

Yes 0.3%

Z�Z�/LGRFDLQH(HCI)

��[���*����ú ��[���*����ú ��[���*����ú

HA fillers for use in the 8-point lift: the Juvéderm® family

+LYTHS�MPSSLYZ�OH]L�ILJVTL�H�WVW\SHY�TLHUZ�VM�HKKYLZZPUN�JVU[V\Y�KLMLJ[Z�HUK�ZVM[�[PZZ\L�H\NTLU[H[PVU�4�>P[OPU�[OL�SHZ[�KLJHKL��[OL`�OH]L�L_WVULU[PHSS`�YPZLU�PU�WVW\SHYP[`�¶�H�[YLUK�SPRLS`�[V�OH]L�ILLU�JVTWLSSLK�I`�JVUZ\TLYZ�ZLLRPUN�TPUPTHSS`�PU]HZP]L�YLQ\]LUH[PVU�WYVJLK\YLZ�[OH[�HYL�NLULYHSS`�^LSS�[VSLYH[LK�5

;OL�SH[LZ[�NLULYH[PVU�VM�1\]tKLYT®�/(�MPSSLYZ��K\L�[V�[OLPY�HK]HUJLK�[LJOUVSVN �̀�WYV]PKL�]LYZH[PSP[`�HUK�MSL_PIPSP[`�MVY�OHYTVUPV\Z�YLQ\]LUH[PVU�HUK�LUOHUJLTLU[�VM�[OL�MHJL�

Replacing volume and structure with the VYCROSSTM collection of HA fi llers

The versatility of the VYCROSSTM collection

Juvéderm® VOLBELLA® with Lidocaine

Juvéderm® VOLIFT ® with Lidocaine

Juvéderm® VOLUMA® with Lidocaine

Prod

uct

code

Pack

agin

gH

A C

once

ntra

tion

Lido

cain

e,H

Z`�V

^�

Syst

emRe

com

men

ded

Indi

catio

ns

Page 6: Juvederm brochure 8 points lift

9LVLEO\�SDUWLFXODWHNot cohesive

Smooth cohesive Smooth cohesive

HYALURONIC ACID CHAINS

HYALURONIC ACID CHAINS

HYALURONIC ACID CHAINS

2WKHU�WHFKQRORJLHV �'�PDWUL[�WHFKQRORJ\Juvéderm® 8/75$�UDQJH 9\FURVV™�WHFKQRORJ\

The Juvéderm® range of fi llersuses proprietary technology

The use of the proprietary Vycross™ technology produces malleable yet cohesive fi llers.8

NASHA technology

3D matrix technology

VYCROSSTM technology6

The VycrossTM technology provides a unique patented combination of majority low HUK�TPUVYP[`�OPNO�TVSLJ\SHY�^LPNO[�/(�MVY�TVYL�LM�JPLU[�JYVZZ�SPURPUN�YLZ\S[PUN�PU!

z�Minimal swelling, longer duration7,8 and enhanced smoothness16

Identifying patients

.H\� l Pendant cross linker l Fully reacted cross linker

SHORT CHAIN

LONG CHAIN

Page 7: Juvederm brochure 8 points lift

Identifying patients

Facial assessment and treatment planning

When approaching patients, it is important to consider how volume can accentuate the natural features.

Facial assessment

-HJPHS�HZZLZZTLU[�PU]VS]LZ�VIQLJ[P]LS`�NYHKPUN�[OL�upper, mid and lower face in terms of structure, proportion and symmetry��;OPZ�HSSV^Z�[OL�KL]LSVWTLU[�VM�H�MHJPHS�[YLH[TLU[�WSHU�[OH[�JHU�\WNYHKL�[OL�MHJL�HZ�H�^OVSL�9

7O`ZPJHS�L_HTPUH[PVU�HUK�H��WOV[VNYHWOPJ�HZZLZZTLU[���^OLYLI`�WOV[VNYHWOZ�HYL�[HRLU�MYVT�Ä�]L�KPMMLYLU[�HUNSLZ��MYVU[�]PL �̂�VISPX\L�YPNO[�HUK�SLM[��M\SS�WYVÄ�SL�YPNO[�HUK�SLM[��HUK�K\YPUN�ZP_�KPMMLYLU[�L_WYLZZPVUZ��H[�YLZ[��RPZZPUN��M\SS�ZTPSL��MYV^UPUN��YHPZPUN�IYV^Z�HUK�SLHUPUN�MVY^HYK��HYL�]LY`�\ZLM\S��HZ�P[�HSSV^Z�V]LYHSS�L]HS\H[PVU�VM�volume loss as well as facial appearance�

0THNLZ�JV\Y[LZ`�VM�+Y�+L�4HPV�HUK�(SSLYNHU��

Photographs can act as an effective tool for educating patients on their facial appearance and to explain

the rationale for the treatment plan by demonstrating the effects of ageing on the features of the face.9

Treatment planning

Facial shape and volume�OH]L�ILLU�YLJVNUPaLK�HZ�RL`�MLH[\YLZ�PU�the perception VM�`V\[OM\SULZZ�1� 0UQLJ[HISL�Ä�SSLYZ�OH]L�ZOV^U�H�reduction in the perception of a patient’s apparent age�MYVT����� �`LHYZ�10

<UKLYZ[HUKPUN�H�WH[PLU[»Z�WLYJLW[PVU�HUK�[OLPY�TV[P]H[PVUZ�HYL�[OLYLMVYL�JY\JPHS�MVY�HU�LMMLJ[P]L�[YLH[TLU[�WSHU! ���

7DNH�SKRWRV�IURP�GLIIHUHQW�DQJOHV 7DNH�SKRWRV�RI�GLIIHUHQW�IDFLDO�H[SUHVVLRQV

;OPZ�JHU�VWLU�KVVYZ�[V�V[OLY�HYLHZ[OH[�[OL�WH[PLU[�^HZ�UV[�H^HYL�VM�VY�

KPK�UV[�YLJVNUPaL�[V�IL�H�WYVISLT��0[�JHU�LUJV\YHNL�[OLT�[V�ZLL�IL`VUK�^YPURSLZ�

[V�KLLWLY�Z[Y\J[\YHS�WYVISLTZ�

Explain that as the ageing process is continual, treatment plans and goals will need to be adapted in order to optimize and maintain

desired appearance2,3

0[�PZ�OLSWM\S�[V�HJJLZZ�H�KLLWLY\UKLYZ[HUKPUN�VM�[OL�[YLH[TLU[�WSHUHUK�^OH[�HYLHZ�ZOV\SK�IL�WYPVYP[PaLK�

Develop an understanding of patients’ motivations and perceptions of beauty

(ZR�[OL�WH[PLU[!�^OH[�KV�`V\�ZLL& (ZR�[OL�WH[PLU[!�^OPJO�HYLHZ�KV�`V\�[OPUR�HYL�^VYZL�[OHU�V[OLYZ&

9LZ\S[Z�[OH[�[OL�WH[PLU[�ZOV\SK�L_WLJ[�MYVT�[OLPY�[YLH[TLU[�WSHU�ZOV\SK�IL�KPZJ\ZZLK��;OL�PTWVY[HUJL�VM�HKOLYPUN�[V�[YLH[TLU[�HUK�MVSSV^�\W�PU[LY]HSZ�ZOV\SK�IL�OPNOSPNO[LK����

Page 8: Juvederm brochure 8 points lift

Practical guide to the 8-point lift

Practical guide to the 8-point lift

;OL���WVPU[�SPM[�OHZ�ILLU�KLZPNULK�[V�WYVTV[L�H�SPM[PUN�LMMLJ[�PU�WH[PLU[Z�^OV�OH]L�SVZ[�]VS\TL�VY�KLZPYL�Z[Y\J[\YHS�LUOHUJLTLU[�[V�HJJLU[\H[L�JLY[HPU�MHJPHS�MLH[\YLZ�

Suitable for a variety

of patients†

Very little downtime

Natural result

Advantages of the 8-point lift 2,3

† 7H[PLU[Z�^P[O�ZL]LYL�ZHNNPUN�ZRPU�ZOV\SK�IL�HWWYVHJOLK�^P[O�JH\[PVU�

Important aspects to consider before treatment:

1. 1. 1. Where to injectWhere to injectWhere to inject

2.2.2. What sequence to injectWhat sequence to injectWhat sequence to inject

3.3.3. What product to injectWhat product to injectWhat product to inject

4.4.4. How much to injectHow much to injectHow much to inject

Page 9: Juvederm brochure 8 points lift

Understanding facial anatomy

)LMVYL�Z[HY[PUN�PUQLJ[PVUZ�VM�=@*96::;4��WYVK\J[Z�PU�[OL���WVPU[�SPM[�Z[YH[LN �̀�P[�PZ�L_[YLTLS`�PTWVY[HU[�[OH[�[OL�PUQLJ[VY�PZ�HWWYVWYPH[LS`�[YHPULK��;OL�PUQLJ[VY�T\Z[�OH]L�HU�L_JLSSLU[�RUV^SLKNL�VM�MHJPHS�HUH[VT �̀�PUJS\KPUN�[OL�SVJH[PVUZ�VM�ISVVK�]LZZLSZ�HUK�ULY]LZ��0U�VYKLY�[V�H]VPK�\U^HU[LK�VY�HK]LYZL�LMMLJ[Z��PUQLJ[PVUZ�T\Z[�H]VPK�PUQ\Y`�[V�ULY]LZ�HUK�ZOV\SK�UV[�IL�THKL�PU[V�ISVVK�]LZZLSZ��;OLYLMVYL��HZWPYH[L�ILMVYL�PUQLJ[PUN�/(�[V�KL[LJ[�HU`�WYLZLUJL�VM�ISVVK�HZ�P[�^PSS�PUKPJH[L�PU[YH]HZJ\SHY�PUQLJ[PVU��0M�`V\�KL[LJ[�ISVVK��PTTLKPH[LS`�Z[VW�PUQLJ[PUN��^P[OKYH^�[OL�ULLKSL��JVTWYLZZ�HUK�JOVVZL�H�KPMMLYLU[�PUQLJ[PVU�ZP[L��(Z�LHJO�WLYZVU»Z�HUH[VT`�JHU�IL�ZSPNO[S`�KPMMLYLU[��JHYLM\S�PUZWLJ[PVU�VM�LHJO�WH[PLU[»Z�MHJL�PZ�ULJLZZHY`�MVY�[OLZL�]HZJ\SHY�Z[Y\J[\YLZ��

Practical guide to the 8-point lift

)RU�LOOXVWUDWLYH�SXUSRVHV�RQO\��Variations in anatomy exist and can differ from patient to patient.

Nerves

Muscle

1� -YVU[HSPZ�T�

2� ;LTWVYHSPZ�T�

3� *VYY\NH[VY�T�

4� 5HZHSPZ�T�

5 Levator labii � Z\WLYPVYPZ�T�

6� A`NVTH[PJ\Z�TPUVY�T�

7� A`NVTH[PJ\Z�THQVY�T�

8� +LWYLZZVY�ZLW[P�T�

9� 9PZVYP\Z�T�

10� 6YIPJ\SHYPZ�VYPZ�T�

11� +LWYLZZVY�HUN\SP�VYPZ�T�

12� +LWYLZZVY�SHIPP�� PUMLYPVYPZ�T�

13� 4LU[HSPZ�T�

14� 7YVJLY\Z�T�

15� 6YIPJ\SHYPZ�VJ\SP�T�

16� 7HYV[PK�NSHUK

17� )\JJHS�MH[�WHK

18� 4HZZL[LY�T�

19� :\ITHUKPI\SHY�� ZHSP]HY`�NSHUK�

20� 7SH[`ZTH�T�

1� :\WYHVYIP[HS�U��� �TLKPHS�IYHUJO�

2� :\WYHVYIP[HS�U��� �SH[LYHS�IYHUJO�

3� :\WYH[YVJOSLHY�U�

4� 0UMYH[YVJOSLHY�U�

5� 3HJYPTHS�U�

6� ,_[LYUHS�UHZHS�U�

7� 0UMYHVYIPHS�U�

8� )\JJHS�IYHUJO�VM�� MHJPHS�U�

9� 4LU[HS�U�

1� :\WYHVYIP[HS�H�

2� :\WYHVYIP[HS�]�

3� :\WLY�JPHS�[LTWVYHS�H��� �� �MYVU[HS�IYHUJO�

4� :\WLY�JPHS�[LTWVYHS�]��� �� �MYVU[�IYHUJO�

5� :\WYH[YVJOSLHY�H�

6� :\WYH[YVJOSLHY�]�

7� 0UMYHVYIP[HS�H�

8� 0UMYHVYIP[HS�]�

9� -HJPHS�]�

10� -HJPHS�H�

11� 4LU[HS�]�

12� 4LU[HS�H�

13� :\ITLU[HS�H�

14� :\ITLU[HS�]�

15� ,_[LYUHS�JHYV[PK�H�

1

2

3

4

5

6

7

8

9

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

Anatomy of the face11,12

� :\WLY�JPHS�[LTWVYHS�H��� �

� :\WLY�JPHS�[LTWVYHS�]��� �

Circulation

4

5

1

2

6

7

8

9

10

11

12

13

14

15

3

Page 10: Juvederm brochure 8 points lift

Practical guide to the 8-point lift

;YLH[TLU[�VM�[OL�JOLLRIVULZ�^P[O�]VS\TL�TH`�PTWYV]L�[OL�HWWLHYHUJL�VM�[OL�UHZVSHIPHS�MVSK�HUK�ZOVY[LU�[OL�SPK�JOLLR�Q\UJ[PVU���

;OPZ�JSLHYS`�ZOV^Z�PTWYV]LTLU[�PU�HU�HYLH�[OH[�OHZ�UV[�ILLU�KPYLJ[S`�PUQLJ[LK��53-�VY�[LHY�[YV\NO��I`�PUQLJ[PUN�PU[V�P[Z�ULPNOIV\YPUN�HYLH��JOLLRIVUL�VY�TPK�JOLLR�����

;OYV\NO�\UKLYZ[HUKPUN�VM�[OPZ�YH[PVUHSL��[OL�[YLH[TLU[�VM�[OL�QH^SPUL��WYL�QV^S�Z\SJ\Z�HUK�THYPVUL[[L�SPULZ�ZOV\SK�Z[HY[�PU�[OL�\WWLY�TPK�MHJL�HSVUN�[OL�a`NVTH[PJ�HYJO�HUK�JOLLRIVULZ����

1.1.1. Where to inject? Where to inject? Where to inject?

>OLU�L]HS\H[PUN�[OL�HYLHZ�[V�PUQLJ[��P[�PZ�PTWVY[HU[�[V�YLTLTILY�[OH[�JYLH[PUN�Z[Y\J[\YL�HUK�]VS\TL�PU�VUL�HYLH�VM�[OL�MHJL�TH`�SLHK�[V�PTWYV]LTLU[�PU�HUV[OLY��HKQHJLU[�WHY[����

0THNL�JV\Y[LZ`�VM�+Y�+L�4HPV�HUK�(SSLYNHU��0THNL�JV\Y[LZ`�VM�+Y�+L�4HPV�HUK�(SSLYNHU��

,_WSHUH[PVUZ�MVY�LHJO�WVPU[�HYL�HZ�MVSSV^Z!

Point 1: Zygomatic arch 3PM[PUN�WVPU[�VM�SH[LYHS�JOLLRIVUL��0[�PZ�[OL��YZ[�HUJOVYPUN�WVPU[��HUK�YLK\JLZ�[OL�]VS\TL�YLX\PYLTLU[�VM�WVPU[Z���HUK���

Point 2: Cheekbone7YVQLJ[PVU�VM�JOLLRIVULZ�HUK�ZOVY[LUPUN�VM�WHSWLIYHS�THSHY�Z\SJ\Z�

Point 3: Mid-cheek region0TWYV]LTLU[�VM�[OL�TLKPHS�SPK�JOLLR�Q\UJ[PVU�HUK�JVUZLX\LU[�ZVM[LUPUN�VM�[OL�[LHY�[YV\NO��

Point 4: Canine fossa and nasolabial fold3LZZ�]VS\TL�PZ�ULLKLK�HM[LY�HYLHZ������HUK���HYL�[YLH[LK��

Point 5: Marionette lines:[HY[�MYVT�[VW�[V�IV[[VT�[V�Z[YLUN[OLU�HUK�SPM[�[OL�T\JVZH�VM�[OL�VYHS�JVTTPZZ\YL��

Point 6: Pre-jowl sulcus:THSS�IVS\Z�VY�SPULHY�YL[YVNYHKL�[LJOUPX\LZ�HYL�Z\P[HISL�OLYL��+V�UV[�PUQLJ[�[OL�QV^SZ��

Point 7: Jawline3PULHY�HUK�YL[YVNYHKL�[LJOUPX\L�PZ�WYLMLYHISL�H[�[OPZ�SL]LS��7VZ[�QV^S��THUKPISL�IVK`�HUK�HUNSL�TH`�IL�PUQLJ[LK��

Point 8: Sub-malar region(KKYLZZLZ�[OL�Z\URLU�HYLH�H[�[OPZ�ZP[L�HUK�HSZV�JVTWYPZLZ�[OL�Z\I�THSHY�]VS\TL�SVZZ��0[�PZ�HUJPSSHY`�[V�[OL�SPM[PUN�LMMLJ[��)VS\Z�VY�MHU�PUQLJ[PVU�[LJOUPX\L�^PSS�KLWLUK�VU�[OL�ZPaL�VM�[OL�HYLH��

;OL�ZLX\LUJL�VM�PUQLJ[PVU�HUK�ZWLJPÄ�J�ZP[LZ�ZOV\SK�IL�HKHW[LK�IHZLK�VU�LHJO�WH[PLU[»Z�WYVÄ�SL�[V�HJOPL]L�[OL�VW[PTHS�V\[JVTL�

2.2.2. What is the best sequence of injections for your patient? What is the best sequence of injections for your patient? What is the best sequence of injections for your patient? 2,32,32,3

;OL�WVZP[PVU�HUK�ZLX\LUJL�VM�[OL�PUQLJ[PVUZ�PZ�ZOV^U�PU�[OL�WOV[VNYHWO��:THSS�IVS\Z�PUQLJ[PVUZ�PU�[OLZL�ZP[LZ�^PSS�HUJOVY�HUK�IYPUN�Z\WWVY[�[V�[OL�MHJL��)`�PUQLJ[PUN�PU�[OL�ZLX\LUJL�ZOV^U��[OL�]VS\TL�VM�WYVK\J[�\ZLK�JHU�IL�TPUPTPZLK��`L[�Z[PSS�HJOPL]L�TH_PT\T�LMMLJ[�

2

1

7

48

3

6

5

Page 11: Juvederm brochure 8 points lift

Practical guide to the 8-point lift

First direct thepatient to lean forward (eyes up, chin down)

so as to demarcate the GO/NO GO areas

prior to injecting.

In addition to Juvéderm® VOLUMA® with Lidocaine and Juvéderm® VOLIFT® with Lidocaine used in the 8-point lift,

Juvéderm® VOLBELLA® with Lidocaine can also be used

to treat the lip, peri-oral and peri-orbital

areas if desired.

Where NOT to inject 2,3

7H[PLU[Z�^P[O�ZL]LYL�ZHNN`�ZRPU�ZOV\SK�IL�PUQLJ[LK�^P[O�JH\[PVU��(U`�WYVK\J[�PUQLJ[LK�PU[V�[OL�NO GO HYLHZ��YLK�JPYJSLZ��TH`�SLHK�[V�^VYZLUPUN�VM�[OL�MVSK�VY�ZHNNPULZZ��;OLZL�HYL�[OL�HYLHZ�[OH[�^VYZLU�HUK�MVSK�^OLU�[OL�WH[PLU[�SLHUZ�MVY^HYK��

The NO GO areas

;OL�IS\L�JPYJSLZ�PU�[OL�KPHNYHT�HYL�[OL�HYLHZ�[V�PUQLJ[�PU�[OL���WVPU[�Z[YH[LN`!�[OL�GO�HYLHZ��

The GO areas

0THNLZ�JV\Y[LZ`�VM�+Y�+L�4HPV�HUK�(SSLYNHU��

0THNLZ�JV\Y[LZ`�VM�+Y�+L�4HPV�HUK�(SSLYNHU�

PointPointPoint ProductsProductsProducts

1.1.1. Zygomatic archZygomatic archZygomatic arch JuvédermJuvédermJuvéderm®®® VOLUMA VOLUMA VOLUMA® ® ® VOLUMA® VOLUMA VOLUMA VOLUMA® VOLUMA® VOLUMA® VOLUMA VOLUMA VOLUMA® VOLUMA with Lidocainewith Lidocainewith Lidocaine

2.2.2. CheekboneCheekboneCheekbone JuvédermJuvédermJuvéderm®®® VOLUMA VOLUMA VOLUMA

® ® ® with Lidocainewith Lidocainewith Lidocaine

3.3.3. Mid-cheek regionMid-cheek regionMid-cheek region JuvédermJuvédermJuvéderm®®® VOLUMA VOLUMA VOLUMA

® ® ® with Lidocainewith Lidocainewith Lidocaine

4.4.4. Nasolabial foldsNasolabial foldsNasolabial folds JuvédermJuvédermJuvéderm®®® VOLIFT VOLIFT VOLIFT

® ® ® with Lidocainewith Lidocainewith Lidocaine

5.5.5. Marionette lines (mouth frown)Marionette lines (mouth frown)Marionette lines (mouth frown) JuvédermJuvédermJuvéderm®®® VOLIFT VOLIFT VOLIFT

® ® ® with Lidocainewith Lidocainewith Lidocaine

6.6.6. Pre-jowl areaPre-jowl areaPre-jowl area JuvédermJuvédermJuvéderm®®® VOLUMA VOLUMA VOLUMA

® ® ® with Lidocainewith Lidocainewith Lidocaine

7.7.7. JawlineJawlineJawline JuvédermJuvédermJuvéderm®®® VOLUMA VOLUMA VOLUMA

® ® ® with Lidocainewith Lidocainewith Lidocaine

8.8.8. Cheek regionCheek regionCheek region JuvédermJuvédermJuvéderm®®® VOLUMA VOLUMA VOLUMA

® ® ® with Lidocainewith Lidocainewith Lidocaine

3.3.3. Which products to inject and where Which products to inject and where Which products to inject and where

BEFORE AFTER

Page 12: Juvederm brochure 8 points lift

Practical guide to the 8-point lift

4.4.4. How much to inject? How much to inject? How much to inject?

;OL�HTV\U[�PUQLJ[LK�WLY�WVPU[�^PSS�]HY`�MYVT�WH[PLU[�[V�WH[PLU[��KLWLUKPUN�VU�[OL�WH[PLU[»Z�ULLK��KLNYLL�VM�]VS\TL�SVZZ�HUK�IVUL�Z[Y\J[\YL��

@V\UNLY�WH[PLU[Z�^P[O�TPSK�[V�TVKLYH[L�ZHNNPUN�TH`�ULLK�H�[V[HS�PUQLJ[PVU�]VS\TL�VM�HWWYV_PTH[LS`���T3�VM�1\]tKLYT®�=63<4(® ^P[O�3PKVJHPUL��6SKLY�WH[PLU[Z�^P[O�TVYL�ZL]LYL�]VS\TL�KLÄ�JPLUJ`�TH`�ULLK���T3�VY�TVYL��5V�TVYL�[OHU�����T3�ZOV\SK�IL�PUQLJ[LK�WLY�WVPU[�

The following patient case studies provide an example of volumes that may be injected at each point

7VPU[��!�����T3�7VPU[��!�����T37VPU[��!�����T37VPU[��!������T3�

7VPU[��!������T37VPU[��!������T37VPU[��!������T3

;V[HS�PUQLJ[PVU�]VS\TL!�

$GDSWHG�IURP�'H�0DLR�&DVH�6WXG\B$VLD�3DFLð�F13

7VPU[��!�����T3�7VPU[��!�����T37VPU[��!�����T37VPU[��!�����T3

7VPU[��!�����T37VPU[��!�����T3�7VPU[��!�����T37VPU[��!�����T3�

;V[HS�PUQLJ[PVU�]VS\TL!�

Adapted from De Maio M. 20122�DQG�'H�0DLR��5]DQ\3

;OLZL�HYL�L_HTWSL�WH[PLU[�JHZL�Z[\KPLZ�HUK�UV[�H�WYLJPZL�YLJVTTLUKH[PVU�

Scheduling treatments

9LZ\S[Z�HYL�ILZ[�L]HS\H[LK�H[�^LLR���HUK�^LLR����0[�PZ�[OLYLMVYL�YLJVTTLUKLK�[OH[�WH[PLU[Z�HYL�PU]P[LK�[V�JVTL�IHJR�MVY�HU�HZZLZZTLU[�K\YPUN�[OPZ�[PTL�WLYPVK��MVSSV^LK�I`�M\Y[OLY�JVUZ\S[H[PVUZ�H[������TVU[OZ�PU[LY]HSZ��;OPZ�^PSS�OLSW�[V�THPU[HPU�HU�VW[PTHS�SVVR�HUK�LZ[HISPZO�HU`�ULLK�MVY�M\Y[OLY�LUOHUJLTLU[�VY�V[OLY�HLZ[OL[PJ�WYVK\J[Z�

Explain that as the ageing process is continual, treatment plans and goals will need to change in order

to optimize and maintain desired appearance

For you and your patient

;OL���^LLRZ�MVSSV^PUN�[YLH[TLU[�HYL�PTWVY[HU[��;V�H]VPK�IHJ[LYPHS�contamination14��KPYLJ[�`V\Y�WH[PLU[�[V!

z�4PUPTPZL�[V\JOPUN�[OL�PUQLJ[PVU�ZP[LZ14

z�(]VPK�THRL�\W�MVY����OV\YZ15

z�0KLHSS �̀�H]VPK�M\Y[OLY�[YLH[TLU[Z�PU�[OPZ�HYLH�MVY���KH`Z14

z�*VU[HJ[�`V\�\WVU�[OL�HWWLHYHUJL�VM�\U\Z\HS�Z`TW[VTZ

3OHDVH�UHIHU�WR�WKH�')8�VXSSOLHG�ZLWK�HDFK�SURGXFW�IRU�DGGLWLRQDO�LQIRUPDWLRQ�

2

1

7

48

3

6

5

5.5.5. Post-injection guidelines Post-injection guidelines Post-injection guidelines

Page 13: Juvederm brochure 8 points lift

1.�/VMMTHUU�2��)4*�+LYTH[VSVN`����� "9!�� ��2.�+L�4HPV�4�� BHIZ[YHJ[D�� 0U!�7YVNYHTTL�HUK�(IZ[YHJ[Z��)LH\[`�;OYV\NO�:JPLUJL�� 0U[LYUH[PVUHS�(LZ[OL[PJ�:`TWVZP\T�:[VJROVST��������3.�+L�4HPV�4�� �9aHU`�)���PU�WYLZZ��̧ ;OL���WVPU[�SPM[¹��0UQLJ[HISL�-PSSLYZ�PU�(LZ[OL[PJ�4LKPJPUL���UK�LK���¶�:WYPUNLY��4.�3\LIILYKPUN�:�� �(SL_PHKLZ�(YTLUHRHZ�4��1��+Y\NZ�+LYTH[VS������"11� �!�����������5.�.PSILY[�,��L[�HS��1�+Y\NZ�+LYT[VS������"11� �!��� �������6.�7H[LU[�VU�[OL�WVS`TLYPaH[PVU�VM� [OL� SV^� HUK� OPNO�TVSLJ\SHY�^LPNO[� WVS`ZHJJOHYPKLZ�<:������ � ��� 7.� ,JJSLZ[VU�+�� �4\YWO`�+2��*SPU� *VZTL[� 0U]LZ[PN� +LYTH[VS�� ����"5!���������8.�9HZWHSKV�/��1��*VZTL[�3HZLY�;OLY������"10�!���������9.�+L�4HPV�,_WLY[�0UZPNO[Z�K\YPUN�^VYRZOVWZ��10.�;H\I�(-��L[�HS��+LYTH[VS�:\YN� ����"36���!���������11.�,UKVZJVWPJ�7SHZ[PJ�:\YNLY`��)VZ[^PJR��,H]LZ�5HOHP���Z[�LKP[PVU��12.�*SLTLU[L�(UH[VT`���(�9LNPVUHS�([SHZ�VM�[OL�/\THU�)VK`���[O�LKP[PVU��13.�+H[H�VU�Ä�SL��+L�4HPV�*HZL�:[\K`F(ZPH�7HJPÄ�J��14.�4VUOLP[�.+�� �9VOYPJO�91��+LYTH[VS�:\YN���� "35�:\WWS��!�� ��������15.�1<=i+,94®�=63),33(®�^P[O�3PKVJHPUL�+-<�B+PYLJ[PVUZ�MVY�<ZLD��9L]PZPVU��������� �����+-<Z�HYL�H]HPSHISL�PUZPKL�[OL�WYVK\J[�IV_�VY�MYVT�`V\Y�SVJHS�(SSLYNHU�YLWYLZLU[H[P]L��16. Allergan Data on -PSL��4PJYVZJVWPJ�VIZLY]H[PVUZ�MVY�Ä�SSLY�WYVK\J[Z�

1.�/VMMTHUU�2��)4*�+LYTH[VSVN`����� "9!�� ��2.�+L�4HPV�4�� BHIZ[YHJ[D�� 0U!�7YVNYHTTL�HUK�(IZ[YHJ[Z��)LH\[`�;OYV\NO�:JPLUJL�� 0U[LYUH[PVUHS�(LZ[OL[PJ�:`TWVZP\T�:[VJROVST��������3.�+L�4HPV�4�� �9aHU`�)���PU�WYLZZ��̧ ;OL���WVPU[�SPM[¹��0UQLJ[HISL�-PSSLYZ�PU�(LZ[OL[PJ�4LKPJPUL���UK�LK���¶�:WYPUNLY��4.�3\LIILYKPUN�:�� �(SL_PHKLZ�(YTLUHRHZ�4��1��+Y\NZ�+LYTH[VS������"11� �!�����������5.�.PSILY[�,��L[�HS��1�+Y\NZ�+LYT[VS������"11� �!��� �������6.�7H[LU[�VU�[OL�WVS`TLYPaH[PVU�VM� [OL� SV^� HUK� OPNO�TVSLJ\SHY�^LPNO[� WVS`ZHJJOHYPKLZ�<:������ � ��� 7.� ,JJSLZ[VU�+�� �4\YWO`�+2��*SPU� *VZTL[� 0U]LZ[PN� +LYTH[VS�� ����"5!���������8.�9HZWHSKV�/��1��*VZTL[�3HZLY�;OLY������"10�!���������9.�+L�4HPV�,_WLY[�0UZPNO[Z�K\YPUN�^VYRZOVWZ��10.�;H\I�(-��L[�HS��+LYTH[VS�:\YN� ����"36���!���������11.�,UKVZJVWPJ�7SHZ[PJ�:\YNLY`��)VZ[^PJR��,H]LZ�5HOHP���Z[�LKP[PVU��12.�*SLTLU[L�(UH[VT`���(�9LNPVUHS�([SHZ�VM�[OL�/\THU�)VK`���[O�LKP[PVU��13.�+H[H�VU�Ä�SL��+L�4HPV�*HZL�:[\K`F(ZPH�7HJPÄ�J��14.�4VUOLP[�.+�� �9VOYPJO�91��+LYTH[VS�:\YN���� "35�:\WWS��!�� ��������15.�1<=i+,94®�=63),33(®�^P[O�3PKVJHPUL�+-<�B+PYLJ[PVUZ�MVY�<ZLD��9L]PZPVU��������� �����+-<Z�HYL�H]HPSHISL�PUZPKL�[OL�WYVK\J[�IV_�VY�MYVT�`V\Y�SVJHS�(SSLYNHU�YLWYLZLU[H[P]L��16. Allergan Data on -PSL��4PJYVZJVWPJ�VIZLY]H[PVUZ�MVY�Ä�SSLY�WYVK\J[Z�

A new�^OVSL�MHJL�HWWYVHJO�MVY�MHJPHS�YLQ\]LUH[PVU�HUK�LUOHUJLTLU[�\ZPUN�the VYCROSSTM collection

Juvéderm® VOLUMA® with Lidocaine

Juvéderm® VOLIFT ® with Lidocaine

Juvéderm® VOLBELLA® with Lidocaine

�^OVSL�MHJL�HWWYVHJO�MVY�MHJPHS�YLQ\]LUH[PVU�HUK�LUOHUJLTLU[�\ZPUN�the VYCROSS

® VOLUMAJuvéderm® VOLIFT

VOLBELLA

�^OVSL�MHJL�HWWYVHJO�MVY�MHJPHS�YLQ\]LUH[PVU�HUK�LUOHUJLTLU[�\ZPUN�the VYCROSS

VOLUMA VOLIFT ®

VOLBELLA

�^OVSL�MHJL�HWWYVHJO�MVY�MHJPHS�YLQ\]LUH[PVU�HUK�LUOHUJLTLU[�\ZPUN�the VYCROSS

® VOLUMA® VOLIFT ®

VOLBELLA

the -point -point -point -point lift lift-point lift-point

7YLWHYH[PVU�+H[L�(WYPS�����)53����������